Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00925574 · ClinicalTrials.gov registry record · Phase 1
A Study of the Safety and How the Body Affects a Drug (CNTO 1959) in Healthy Volunteers and in Patients With Psoriasis
A Phase 1 study, sponsored by Centocor.
- Completed
- Registry status
- Phase 1
- Development phase
- 71
- Enrollment target
NCT00925574 is a Phase 1 study that has completed, run by Centocor. The registered enrollment target is 71 participants.
The verdict
NCT00925574, a Phase 1 study, has completed, sponsored by Centocor.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 71 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and how the body affects a drug (CNTO 1959) in healthy volunteers and in patients with psoriasis.
Interventions
- DRUG CNTO 1959; Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2009-06-04 |
| Est. Completion | 2010-10-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00925574
The ClinicalTrials.gov registry entry for NCT00925574 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Centocor, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CNTO 1959; Placebo is the first listed.
NCT00925574 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00925574 about?
NCT00925574 is a clinical study titled "A Study of the Safety and How the Body Affects a Drug (CNTO 1959) in Healthy Volunteers and in Patients With Psoriasis". The purpose of this study is to evaluate the safety and how the body affects a drug (CNTO 1959) in healthy volunteers and in patients with psoriasis.
What is the current status of trial NCT00925574?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 71 participants. The study started on 2009-06-04. Estimated completion is 2010-10-11.
What interventions are being tested in trial NCT00925574?
The interventions under investigation include: CNTO 1959; Placebo (DRUG).
Who is sponsoring clinical trial NCT00925574?
This trial is sponsored by Centocor, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.